Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Leonard

Showing results (101-110 of 967) with videos related to

Pageof 97
Sort By:
International Clinical Psychopharmacology|March 1, 1994
Serotonin receptors--where are they going?B E Leonard
International Journal of Radiation Biology|March 16, 2007
Adaptive response and human benefit: Part I. A microdosimetry dose-dependent modelBobby E Leonard
British Journal of Clinical Practice. Supplement|May 1, 1985
Neuropharmacological profile of buspirone: a non-benzodiazepine anxiolytic with specific mid-brain modulating propertiesB E Leonard
Radiation Research|March 10, 2009
The range of the bystander effect signal in three-dimensional tissue and estimation of the range in human lung tissue at low radon levelsBobby E Leonard
Addiction (Abingdon, England)|March 24, 2005
Alcohol and intimate partner violence: when can we say that heavy drinking is a contributing cause of violence?Kenneth E Leonard
Neurochemistry International|May 22, 2010
Current status of the biogenic amine theory of depressionB E Leonard
International Clinical Psychopharmacology|July 1, 1991
Pharmacological and biochemical aspects of therapy-resistant depressionB E Leonard
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1972
Some effects of dl-4-(2-hydroxy-3-isopropylaminopropoxy) indole (LB46) on brain monoamines and their precursorsB E Leonard
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1972
The effects of 3- -dimethylaminopropyl-3-phenylphthalide (I.C.I. 53,165) on brain monoamines and their precursorsB E Leonard
Journal of Psychopharmacology (Oxford, England)|January 28, 2012
Psychoneuroimmunology: An area of interest for the psychopharmacologist?B E Leonard
Pageof 97

Showing results (101-110 of 967) with videos related to

Sort By:
Pageof 97
International Clinical Psychopharmacology|March 1, 1994
Serotonin receptors--where are they going?B E Leonard
International Journal of Radiation Biology|March 16, 2007
Adaptive response and human benefit: Part I. A microdosimetry dose-dependent modelBobby E Leonard
British Journal of Clinical Practice. Supplement|May 1, 1985
Neuropharmacological profile of buspirone: a non-benzodiazepine anxiolytic with specific mid-brain modulating propertiesB E Leonard
Radiation Research|March 10, 2009
The range of the bystander effect signal in three-dimensional tissue and estimation of the range in human lung tissue at low radon levelsBobby E Leonard
Addiction (Abingdon, England)|March 24, 2005
Alcohol and intimate partner violence: when can we say that heavy drinking is a contributing cause of violence?Kenneth E Leonard
Neurochemistry International|May 22, 2010
Current status of the biogenic amine theory of depressionB E Leonard
International Clinical Psychopharmacology|July 1, 1991
Pharmacological and biochemical aspects of therapy-resistant depressionB E Leonard
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1972
Some effects of dl-4-(2-hydroxy-3-isopropylaminopropoxy) indole (LB46) on brain monoamines and their precursorsB E Leonard
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1972
The effects of 3- -dimethylaminopropyl-3-phenylphthalide (I.C.I. 53,165) on brain monoamines and their precursorsB E Leonard
Journal of Psychopharmacology (Oxford, England)|January 28, 2012
Psychoneuroimmunology: An area of interest for the psychopharmacologist?B E Leonard
Pageof 97